Suzhou Sinochem's parent company, Taiwan China Chemical Pharmaceutical Co., Ltd. (hereinafter referred to as Taiwan Sinochem, CCPC), was founded in 1952. It is a large comprehensive pharmaceutical enterprise in Taiwan, which implemented GMP and cGMP earlier in Taiwan. It mainly produces western medicine for human use, traditional Chinese medicine, animal medicine, household health care products, etc., and produces more than 400 kinds of products, with a sales volume of about 700 million yuan in 2000. There is a complete pharmaceutical research center in Taiwan, which is engaged in a series of research and development in fermentation, synthesis, preparation, etc. In the early 1990s, due to the restrictions of Taiwan authorities, many large listed enterprises in Taiwan were affected in their investment in the mainland. However, Sinochem Taiwan, with a long-term vision for development, is committed to the development of medicine in the mainland of China and is determined to do its part. Therefore, in 1993, through its subsidiary Dingmao company in the United States, Sinochem Taiwan signed an investment agreement with the mainland of China to establish Suzhou Sinochem Pharmaceutical Industry Co., Ltd., which is a comprehensive pharmaceutical enterprise in Taiwan that invests in the mainland of China and a large-scale Taiwan funded pharmaceutical enterprise so far.